ArticleCurrent oncology (Toronto, Ont.)2017
Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma.
V Babashov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it
ArticleCurrent oncology (Toronto, Ont.)2017
V Babashov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.